Home Healthcare Healthcare Services Clinical Trial Logistics Market

Clinical Trial Logistics Market Size, Share & Trends Analysis Report By Service (Transportation, Warehousing & Distribution, Value-Added Services (Labelling, Kitting, QP Release)), By Clinical Phase (Phase I, Phase II, Phase III, Phase IV / post-marketing), By Therapeutic Area (Oncology, Cardiovascular Diseases, Rare / Orphan Diseases, Immunology & Inflammation, Endocrine & Metabolic Disorders, Neurology & Psychiatry, Others), By End-user (Bio-Pharma Manufacturers, CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations), Hospitals & Clinical-Trial Sites, Other End Users), By Temperature Range (Cold Chain) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 09, 2025 | Author: Debashree B | Format: | Report Code: SR7499DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  7. North America Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    7. U.S.
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    8. Canada
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  8. Europe Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    7. U.K.
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    8. Germany
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    9. France
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    10. Spain
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    11. Italy
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    12. Russia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    13. Nordic
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    14. Benelux
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    15. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  9. APAC Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    7. China
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    8. Korea
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    9. Japan
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    10. India
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    11. Australia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    12. Taiwan
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    13. South East Asia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    14. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  10. Middle East and Africa Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    7. UAE
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    8. Turkey
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    9. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    10. South Africa
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    11. Egypt
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    12. Nigeria
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    13. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  11. LATAM Clinical Trial Logistics Market Size Analysis
    1. Introduction
    2. Clinical Trial Logistics Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Transportation
        1. Road
        2. Air
        3. Others
      2. Warehousing & Distribution
      3. Value-Added Services (Labelling, Kitting, QP Release)
    3. Clinical Trial Logistics Market Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV / post-marketing
    4. Clinical Trial Logistics Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases
      3. Rare / Orphan Diseases
      4. Immunology & Inflammation
      5. Endocrine & Metabolic Disorders
      6. Neurology & Psychiatry
      7. Others
    5. Clinical Trial Logistics Market Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
      1. Bio-Pharma Manufacturers
      2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
      3. Hospitals & Clinical-Trial Sites
      4. Other End Users
    6. Clinical Trial Logistics Market Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
      1. Cold Chain
        1. Ambient (15-25 °C)
        2. Refrigerated (2–8 °C)
        3. Frozen (0 °C to -20 °C)
        4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    7. Brazil
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    8. Mexico
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    9. Argentina
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    10. Chile
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    11. Colombia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    12. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      3. Market Size & Forecast By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      5. Market Size & Forecast By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      6. Market Size & Forecast By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  12. Competitive Landscape
    1. Clinical Trial Logistics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Arvato SE
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Eurofins Scientific
    3. Almac Group
    4. Thermo Fisher Scientific Inc.
    5. MARKEN
    6. DHL Group
    7. Parexel International (MA) Corporation
    8. Catalent, Inc
    9. PCI
    10. Cencora, inc. 
    11. FedEx
    12. Kuehne+Nagel
    13. Biocair
    14. Movianto
    15. Caprihans India Limited
    16. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.